| scholarly article | Q13442814 |
| P50 | author | Nancy Cox | Q6962616 |
| Timothy M. Uyeki | Q84362200 | ||
| Carolyn B Bridges | Q106395239 | ||
| P2093 | author name string | Keiji Fukuda | |
| Scott A Harper | |||
| Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) | |||
| P433 | issue | RR-6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-40 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Morbidity and Mortality Weekly Report: Recommendations and Reports | Q23930023 |
| P1476 | title | Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) | |
| P478 | volume | 53 |
| Q34776559 | A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment |
| Q33259330 | A comparative analysis of influenza vaccination programs |
| Q47776230 | A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000. |
| Q33404461 | A survey of pediatricians' attitudes regarding influenza immunization in children |
| Q42762223 | Additional seasonal influenza virus vaccinations for the 2009 H1N1 pandemic |
| Q36647988 | Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004 |
| Q36231818 | An Audit of Influenza Vaccination Status in Adults with Inflammatory Bowel Disease |
| Q30372776 | An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. |
| Q30393095 | Antivirals for influenza: strategies for use in pediatrics |
| Q52365716 | Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age. |
| Q64135849 | Association between patient reminders and influenza vaccination status among children |
| Q46542124 | Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. |
| Q37410776 | Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. |
| Q37087777 | Attitudes amongst Australian hospital healthcare workers towards seasonal influenza and vaccination. |
| Q37600176 | Automated Screening of Hospitalized Children for Influenza Vaccination |
| Q36740019 | Balancing the Efficacy and Safety of Vaccines in the Elderly |
| Q36735547 | Beliefs and attitudes about influenza immunization among parents of children with chronic medical conditions over a two-year period |
| Q31159585 | Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions |
| Q37419373 | Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease |
| Q36596993 | Communicable respiratory threats in the ED: tuberculosis, influenza, SARS, and other aerosolized infections |
| Q30421764 | Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: was there a synergistic fetal toxicity associated with the two-vaccine 2009/2010 season? |
| Q39974059 | Complete Influenza Vaccination Trends for Children Six to Twenty-Three Months |
| Q36992781 | Detection of influenza antigenic variants directly from clinical samples using polyclonal antibody based proximity ligation assays |
| Q40005237 | Determinants of Influenza Vaccination Among Young Children in an Inner-City Community |
| Q36737727 | Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine |
| Q24635905 | Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada |
| Q38165876 | Efficacy and effectiveness of maternal influenza vaccination during pregnancy: a review of the evidence. |
| Q34002296 | Emerging infections and pregnancy |
| Q30448118 | Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor |
| Q34720001 | Evaluation of the Quidel QuickVue test for detection of influenza A and B viruses in the pediatric emergency medicine setting by use of three specimen collection methods |
| Q41903059 | Evaluation of three immunoassay kits for rapid detection of influenza virus A and B. |
| Q33725572 | Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene |
| Q52332387 | Examination of the British Columbia Influenza Prevention Policy for healthcare workers: Phase 1 qualitative case study |
| Q30384321 | Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease. |
| Q40713270 | Febrile Seizure Risk After Vaccination in Children 6 to 23 Months |
| Q38760334 | First Trimester Influenza Vaccination and Risks for Major Structural Birth Defects in Offspring |
| Q30384379 | Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection. |
| Q28300001 | Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel |
| Q35792094 | Health benefits, risks, and cost-effectiveness of influenza vaccination of children |
| Q34013584 | Heavy drinking and health promotion activities |
| Q41873536 | How can nurses' flu vaccination rates be boosted? |
| Q34099150 | Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system |
| Q47564024 | Immunization Practices of U.S. Obstetrician/Gynecologists for Pregnant Patients |
| Q36144996 | Immunizations in the United States: a rite of passage |
| Q37197106 | Impact of a multi-component antenatal vaccine promotion package on improving knowledge, attitudes and beliefs about influenza and Tdap vaccination during pregnancy |
| Q36918161 | Impact of a school-based influenza immunization program on disease burden: comparison of two Tennessee counties |
| Q36746485 | Impact of clinical preventive services in the ambulatory setting |
| Q35641291 | Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women |
| Q38681293 | Impact of pregnancy on observed sex disparities among adults hospitalized with laboratory-confirmed influenza, FluSurv-NET, 2010-2012. |
| Q30390901 | Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia. |
| Q44180974 | Impact of requiring influenza vaccination for children in licensed child care or preschool programs--Connecticut, 2012-13 influenza season |
| Q74186218 | Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza. Zanamivir Study Group |
| Q35205536 | Improving influenza vaccination rates of high-risk inner-city children over 2 intervention years |
| Q30373090 | In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses. |
| Q90196034 | Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15 |
| Q34099491 | Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States |
| Q30391418 | Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination |
| Q24602991 | Influenza A (H3N2) outbreak, Nepal |
| Q36538429 | Influenza Vaccination Among US Children With Asthma, 2005-2013 |
| Q37568360 | Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses |
| Q47809608 | Influenza Vaccine in the Elderly and Chronic Obstructive Pulmonary Disease |
| Q36830435 | Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease |
| Q28079486 | Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety |
| Q36221067 | Influenza and pneumonia in pregnancy |
| Q35283578 | Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps? |
| Q35872982 | Influenza outbreak control in confined settings |
| Q36153722 | Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain |
| Q36153678 | Influenza related hospitalisations in Sydney, New South Wales, Australia. |
| Q64135846 | Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016–17 influenza season |
| Q33292253 | Influenza vaccination coverage: findings from immunization information systems |
| Q51929938 | Influenza vaccination in Dutch nursing homes: is tacit consent morally justified? |
| Q30350930 | Influenza vaccination in the elderly: impact on hospitalisation and mortality. |
| Q30422463 | Influenza vaccination in the face of immune exhaustion: is herd immunity effective for protecting the elderly? |
| Q36136123 | Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons |
| Q83011818 | Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study |
| Q43176122 | Influenza vaccine coverage rates and perceptions on vaccination in South Korea |
| Q33283742 | Influenza vaccine supply, 2005-2006: did we come up short? |
| Q25256617 | Influenza-associated hospitalization in a subtropical city |
| Q42259236 | Influenza-associated pediatric deaths in the United States, 2004-2012. |
| Q34785408 | Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. |
| Q28743079 | Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren |
| Q36046358 | Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection. |
| Q35198268 | Knowledge, attitudes, and acceptability about influenza vaccination in Korean women of childbearing age. |
| Q34461309 | Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells |
| Q42246870 | Maternal influenza vaccination: evaluation of a patient-centered pamphlet designed to increase uptake in pregnancy |
| Q30386781 | Maternal vaccination for the prevention of influenza: current status and hopes for the future. |
| Q37713015 | Multiplex Reverse-Transcription Loop-Mediated Isothermal Amplification Coupled with Cascade Invasive Reaction and Nanoparticle Hybridization for Subtyping of Influenza A Virus |
| Q35530004 | NIAID-Sponsored 2010 Guidelines for Managing Food Allergy: Applications in the Pediatric Population |
| Q30357932 | New vaccines against influenza virus. |
| Q30407716 | Novel vaccines against influenza viruses. |
| Q30420536 | Obstetricians and the 2009–2010 H1N1 Vaccination Effort: Implications for Future Pandemics |
| Q92530860 | Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysis |
| Q35666065 | Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection |
| Q63247527 | Overcoming Barriers and Identifying Opportunities for Developing Maternal Immunizations: Recommendations From the National Vaccine Advisory Committee |
| Q30230654 | Pandemic influenza preparedness: the critical role of the syringe |
| Q39066650 | Parental-Reported Full Influenza Vaccination Coverage of Children in the U.S. |
| Q36989767 | Perception and Attitudes of Korean Obstetricians about Maternal Influenza Vaccination |
| Q40728721 | Pertussis and Influenza Vaccination Among Insured Pregnant Women — Wisconsin, 2013-2014. |
| Q39986418 | Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare |
| Q38911509 | Place of influenza vaccination among children--United States, 2010-11 through 2013-14 influenza seasons |
| Q43725974 | Pneumonia Complicating Pregnancy |
| Q33723582 | Practical considerations to influenza vaccination |
| Q36903940 | Practice and Child Characteristics Associated With Influenza Vaccine Uptake in Young Children |
| Q27478355 | Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines |
| Q30152065 | Prediction of Peaks of Seasonal Influenza in Military Health-Care Data |
| Q30352924 | Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy. |
| Q33257469 | Predictors of colorectal cancer screening in diverse primary care practices |
| Q43175168 | Prevalence and correlates of influenza vaccination among non-institutionalized elderly people: an exploratory cross-sectional survey |
| Q35984547 | Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New? |
| Q35609971 | Preventing influenza: vaccine systems and practices in the Southeast |
| Q37039271 | Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines |
| Q35943670 | Prevention of influenza in the general population |
| Q37596393 | Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care |
| Q30370024 | Prioritization of influenza pandemic vaccination to minimize years of life lost. |
| Q37394608 | Private Pediatric Clinic Characteristics Associated with Influenza Immunization Efforts in the State of Georgia: A Pilot Evaluation |
| Q27693242 | Protection of young children from influenza through universal vaccination. |
| Q33576353 | Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study |
| Q52038032 | Public health approach to emerging infections among pregnant women |
| Q33601906 | Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America |
| Q36934379 | Pulmonary and cardiac infections in athletes |
| Q33801976 | Pulmonary infections in the returned traveller. |
| Q35760689 | Quantifying influenza vaccine efficacy and antigenic distance. |
| Q34704520 | Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study. |
| Q47809619 | Rapid Tests for Influenza |
| Q39647922 | Reasons Why Women Accept or Reject the Trivalent Inactivated Influenza Vaccine (TIV) During Pregnancy |
| Q34580095 | Recombinant Baculovirus Associated with Bilosomes as an Oral Vaccine Candidate against HEV71 Infection in Mice |
| Q94352812 | Recommandations quant à l’usage du vaccin contre l’influenza chez les enfants |
| Q84354864 | Recommendations for the use of influenza vaccine for children |
| Q33639310 | Recruiting primary care clinicians for public health and bioterrorism surveillance |
| Q43098483 | Respiratory illness associated with influenza and respiratory syncytial virus infection |
| Q34462908 | Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain) |
| Q30365596 | Risk management of seasonal influenza during pregnancy: current perspectives. |
| Q36201827 | Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy |
| Q35026642 | Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia |
| Q37186906 | Seasonal influenza in the United States, France, and Australia: transmission and prospects for control |
| Q37040671 | Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children |
| Q33779792 | Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus? |
| Q36650284 | Stability of influenza vaccine coated onto microneedles |
| Q36568801 | The Burden of Influenza in Young Children, 2004–2009 |
| Q64086554 | The Effect of Influenza Vaccination on Mortality and Risk of Hospitalization in Patients With Heart Failure: A Systematic Review and Meta-analysis |
| Q34576732 | The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014 |
| Q37019417 | The impact of missed opportunities on seasonal influenza vaccination coverage for healthy young children |
| Q21563018 | The imperative to share clinical study reports: recommendations from the Tamiflu experience |
| Q36380289 | The management of respiratory infections during pregnancy |
| Q30354213 | The osmotic stress response of split influenza vaccine particles in an acidic environment. |
| Q36171279 | The use of antiviral drugs for influenza: recommended guidelines for practitioners |
| Q28088540 | The weight of obesity on the human immune response to vaccination |
| Q37175425 | Thimerosal Exposure and the Role of Sulfation Chemistry and Thiol Availability in Autism |
| Q37170244 | Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink |
| Q54259409 | Timeliness of Pediatric Influenza Vaccination Compared With Seasonal Influenza Activity in an Urban Community, 2004–2008 |
| Q64131944 | Timeliness of childhood immunizations: a state-specific analysis |
| Q35018543 | Towards a simulation environment for modeling of local influenza outbreaks |
| Q37572600 | Transplacental transfer of oseltamivir carboxylate |
| Q36057515 | Trends in antibiotic use in Massachusetts children, 2000-2009 |
| Q33976189 | Trends in childhood influenza vaccination coverage--U.S., 2004-2012 |
| Q30652766 | Using sequence data to infer the antigenicity of influenza virus |
| Q26820843 | Utilizing health information technology to improve vaccine communication and coverage |
| Q30429782 | Vaccination patterns in pregnant women during the 2009 H1N1 influenza pandemic: a population-based study in Ontario, Canada. |
| Q36964157 | Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons |
| Q24201525 | Vaccines for preventing influenza in healthy children |
| Q47638511 | Vaccines for preventing influenza in healthy children |
| Q35895981 | Vaccines for women age 50 and older |
| Q36303297 | Viral pneumonias other than cytomegalovirus in transplant recipients |
| Q36830439 | When Should Therapy for Inflammatory Bowel Disease Be Stopped? |
| Q80041113 | [Flu vaccination in healthcare workers] |
Search more.